| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2005;45:252.)
© 2005 American Heart Association, Inc.
Scientific Contributions |
From Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Neuropsychiatric Institute, Los Angeles.
Correspondence to Michael Irwin, MD, Norman Cousins Professor Cousins Center for Psychoneuroimmunology, UCLA Neuropsychiatric Institute, 300 Medical Plaza, Suite 3-109, Los Angeles, CA 90095-7057. E-mail mirwin1{at}ucla.edu
| Abstract |
|---|
|
|
|---|
Key Words: alcohol cardiovascular disorders sleep catecholamine
| Introduction |
|---|
|
|
|---|
Experimental sleep deprivation can serve as a naturalistic probe of the homeostatic regulation of sympathetic activity. Loss of sleep induces elevations in circulating levels of epinephrine and norepinephrine,9,10 with attendant increases of blood pressure and heart rate the next day.11,12 In addition, habitual sleep loss and insomnia are markers of subclinical heart disease and are independent predictors of cardiovascular disease risk, particularly in males.13 Fluctuations in sympathetic activity across the sleepwake cycle are thought to contribute to the low rates of sudden cardiac death, myocardial infarction, and ischemic stroke during sleep, as well as to their peak incidence at the end of sleep or in the morning after awakening.14
In alcohol-dependent persons who show abnormalities of sleep continuity and sleep depth at rest,1517 administration of sleep deprivation reveals a defect in these patients ability to recover from even a modest loss of sleep.16 For example, in contrast to the robust recovery of delta sleep found in controls, abstinent alcohol-dependent patients do not generate increases of deep delta sleep after early night partial sleep deprivation (PSD-E).16 In this study, we tested the hypothesis that early night sleep deprivation will induce sympathetic activation in abstinent alcohol-dependent men, and that increases of heart rate, blood pressure, and circulating levels of sympathetic catecholamines will be sustained after recovery sleep in alcoholic subjects as compared with responses in age-, gender-, and ethnicity-matched controls. Subjects were on average normotensive and none was receiving hypertensive medications.
| Materials and Methods |
|---|
|
|
|---|
A total of 99 men fulfilled screening eligibility criteria, gave informed consent, and entered the research protocol. Of this total, 6 participants were excluded because of medical history and/or medication use, 2 controls and 4 alcoholic subjects were released from the study because of positive toxin screens during the sleep protocol or within the 2-week period before assessment, 7 subjects were excluded because of nocturnal myoclonus, 2 alcoholic subjects were released because of decreased oxygen saturation during sleep, and 3 controls and 3 alcoholic subjects did not complete blood sampling. The remaining sample comprised 72 men (36 control subjects, 36 alcoholic patients). All participants were in good health as determined by medical history and laboratory screening blood tests. None fulfilled criteria for primary substance dependence or had used substances in the past 2 weeks, had currently treated hypertension or overt alcohol-related liver disease, showed elevations of liver function tests above the laboratory range of normal; or were using medications known to alter sleep wake activity (eg, ß-blockers, psychotropic medications) within 2 weeks of the sleep protocol. Alcoholic subjects were studied after acute and subacute withdrawal symptoms had resolved; 2 alcoholic patients had been treated with diazepam 30 days before study. Nursing observations and random urine substance screens were used to confirm abstinence during the sleep protocol. Further details about recruitment, diagnostic evaluation procedures, and subjects health have been reported previously.16,17
Procedures
Details about the sleep screening, sleep protocol, and EEG sleep methods have been previously described16,17 and are also found in the online supplement (http://ww.hypertensionaha.org).
For assessment of heart rate and blood pressures, supine resting measures were limited to the morning immediately after awakening; all-night blood pressure monitoring has been found to induce declines of sleep amounts and depth. While subjects remained in the supine position, heart rate was monitored with an ECG and blood pressure was assessed using a blood pressure monitor (Dinamap 1846 SX-P; Critikon, Tampa Bay, Fla) that had been validated within 5 mm Hg of a standard mercury sphygmomanometer. Data on heart rate and blood pressure were obtained from the mean of 3 separate measures taken 5 minutes apart in the first 15 minutes after wakening.
For assay of plasma catecholamines, blood sampling was performed twice at 23:00 hours before "lights out" and at 06:30 hours before awakening via an intravenous catheter that has not been found to alter sleep amounts or depth.15,20 Catecholamines were assayed as previously described.21
Statistical Analyses
Data were analyzed using SPSS version 11.5 for Windows and missing values were substituted by single-point multiple imputation using NORM version 2.03 for any participant who had >95% of their data. Group differences in age, education, body mass index, alcohol consumption histories, and liver function tests were tested using 1-way ANOVAs. To evaluate group and night differences in EEG sleep measures, heart rate, and blood pressure, repeated measures ANOVAs were performed using a 2 (group: alcoholic subjects, controls) x 3 (night: baseline, PSD-E, recovery) design. Circulating levels of epinephrine and norepinephrine were log-transformed to achieve a normal distribution. To evaluate group, night, and time differences in circulating levels of plasma catecholamines, repeated measures ANOVAs were performed using a 2 (group) x 2 (time: 23:00 hours, 06:30 hours) x 3 (night) design. Two covariates, age and ethnicity (white; black), were added a priori to the ANOVA models given evidence that age and black ethnicity are associated with greater catecholamines levels and/or responsiveness to behavioral challenge.22,23 It was not appropriate to include body mass index as a covariate, given the causal effects of chronic alcohol use to reduce body fat mass,24 as well as the high correlations between alcohol consumption and body mass index. The possible confounding influence of body mass index on cardiovascular responses and circulating catecholamines was tested by zero order correlations.
Based on a priori hypotheses, planned comparisons were performed to determine whether administration of sleep deprivation led to increases of cardiovascular responses and norepinephrine and epinephrine in alcoholic subjects as compared with controls. It should be noted that these planned comparisons do not require a significant omnibus F finding to be evaluated appropriately. According to Keppel,25 an unprotected analytic comparison of group differences only occurs when no a priori hypotheses exist or a nonsignificant omnibus F finding is obtained.
| Results |
|---|
|
|
|---|
|
Measures of heart rate and blood measures were obtained the morning after each of the 3 nights: baseline, PSD-E, and recovery. For heart rate, there was a significant night effect [F (2, 130)=21.4, P<0.001] and a significant groupxtime interaction [F (2,126)=6.1, P<0.01; Figure 1A]. There was no group effect. Planned group comparisons tested whether sleep deprivation would lead to increases of heart rate at the 6:30-hour time point in alcoholic subjects as compared with controls. Alcoholic subjects and controls had similar heart rate after baseline night [F (1, 64)=1.9, P=0.17], whereas morning heart rate was higher in alcoholic subjects than controls after PSD-E [F (1, 64)=5.9, P<0.01] and recovery nights [F (1, 64)=3.3, P<0.07]. There was a significant night effect for systolic blood pressure [Figure 1B; F (2, 130)=27.2, P<0.001] and for diastolic blood pressure [F (2, 130)=19.5, P<0.001], in which sleep deprivation induced similar increases of blood pressure in both groups, which were maintained after recovery sleep. There was neither group effect nor groupxnight interaction for either measure of blood pressure.
|
Across the 3 nights, circulating levels of norepinephrine were higher in alcoholic subjects as compared with controls with an overall group effect [F (1, 68)=4.0, P<0.05; Figure 2A]. In addition, norepinephrine showed a night effect [F (2, 136)=6.0, P<0.01] with significant increases after sleep deprivation. There was no time effect or interactions for norepinephrine. Alcoholic subjects and controls had similar levels of norepinephrine at 6:30 hours after the baseline night [F (1, 68)=0.5, P=0.47]. In contrast, after the PSD-E and recovery nights, morning levels of norepinephrine were higher in alcoholic subjects than controls [F (1, 68)=3.5, P=0.05; F (1, 68)=5.8, P<0.05].
|
Similar to the findings for norepinephrine, circulating levels of epinephrine were also higher in the alcoholic subject as compared with the controls across the 3 nights [group effect: F (1, 67)=4.6, P< 0.05; Figure 2B]. Epinephrine significantly changed across the individual nocturnal periods with a time effect [F (1, 67)=7.1, P< 0.05]. There was no main effect for night, and no significant interactions for epinephrine. During the baseline night, alcoholic subjects and controls had similar nocturnal levels of epinephrine [F (1, 67)=1.9, P=0.18]. In contrast, morning levels of epinephrine were significantly higher in alcoholic subjects than controls after PSD-E [F (1, 67)=4.4, P< 0.05] and recovery [F (1, 67)=4.6, P<0.05].
The significant differential increases of heart rate and catecholamine responses to PSD-E in abstinent alcoholic subjects were present when age and black ethnicity were covaried. Neither education nor age correlated with measures of cardiovascular or sympathetic function at any of the time points. The influence of smoking status on cardiovascular and catecholamine responses was tested by additional analyses that stratified the alcoholic subjects into groups of smokers (n=19) and nonsmokers (n=17). There were no main effects of smoking status or interactions for measures of heart rate, systolic blood pressure, diastolic blood pressure, or plasma levels of norepinephrine or epinephrine within the alcoholic subjects (all P>0.1). Furthermore, within the smokers, correlations were nonsignificant between number of cigarettes used per day and cardiovascular measures or plasma catecholamines at any of the time points (all P>0.1). Finally, previous evidence has shown that alcoholic subjects with elevated blood pressure show greater reactivity to behavioral challenge;6 thus, we explored whether alcoholic subjects who differed in blood pressure before the sleep protocol showed differential cardiovascular and sympathetic responses after sleep deprivation. Three subgroups of alcoholic subjects were identified: normotensive (n=21; systolic blood pressure <120 mm Hg and diastolic blood pressure <80 mm Hg); prehypertensive (n=10; systolic blood pressure 120 to 139 mm Hg or diastolic blood pressure 80 to 89 mm Hg); and stage 1 hypertensive (n=5; systolic blood pressure 140 to 159 mm Hg or diastolic blood pressure 90 to 99 mm Hg). Although the normotensive and hypertensive groups showed similar blood responses after sleep loss, epinephrine levels after the recovery night, but not baseline or PSD, were significantly elevated in alcoholic subjects with stage 1 hypertension [F (1, 25)=5.2, P<0.05] or with stage 1 hypertension or prehypertension [F (1, 35)=5.8, P<0.05] as compared with normotensive alcoholic subjects. Levels of norepinephrine were similar for the groups across each of the nights.
| Discussion |
|---|
|
|
|---|
These data extend previous studies of blood pressure reactivity in alcohol-dependent patients,68 and this is the first study to our knowledge that has examined alterations of circulating catecholamines at rest and in response to a behavioral challenge in alcoholic subjects. In male alcoholic subjects who have transient hypertension during alcohol withdrawal,68 administration of a behavioral stressor-induced greater blood pressure increases as compared with controls. Likewise, in women who have had transitory withdrawal hypertension, there is evidence of persistent cardiovascular dysregulation in which diastolic blood pressure is elevated during 2 aversive stressors, hand grip and public speaking, despite normal resting levels.28 In contrast, one other study found that alcohol-dependent patients show a blunted blood pressure response to public speaking stress, although this alteration was thought be caused by a blunted perception of the social threat at the level of the central nervous system.29 In the present study, no differential change in blood pressure was found in the 2 groups, with alcoholic subjects and controls showing similar increases of blood pressure in response to sleep loss. However, to allow for comparison of the effects of alcohol dependence on cardiovascular responses without the confounding effects of hypertensive medications, this study excluded alcoholic subjects who were currently being treated for hypertension. Thus, it is possible that these criteria identified alcoholic subjects who are resistant to exaggerated blood pressure reactivity. Alternatively, hospitalization is known to promote decreases of resting blood pressure, and we speculate that alcoholic subjects dwelling in the community might show differential increases of blood pressure after sleep loss. Nevertheless, in exploratory analyses, we report that alcoholic subjects with prehypertension and/or stage 1 hypertension showed exaggerated increases of epinephrine during recovery from sleep loss as compared with normotensive alcoholic subjects.
Sleep deprivation and disordered sleep lead to daytime overproduction of proinflammatory cytokines,15,20 which are also implicated in the risk for cardiovascular disease.30 We have previously reported that alcoholic subjects show nocturnal elevations of IL-6 and tumor necrosis factor (TNF), which are further exacerbated by sleep deprivation.31 However, the mechanisms that underlie changes in inflammatory cytokines in alcoholism are not known; for example, we found no correlation between measures of circulating catecholamines and plasma concentration of IL-6 or TNF in a subsample of alcoholic subjects and controls (n=27) reported here. Alternatively, increases of vagal tone are associated with declines in the production and circulating levels of TNF.32 Van Cauter et al have suggested that "sleep debt" induces alterations of sympathovagal balance with metabolic and immunologic effects, including increases in expression of proinflammatory cytokines.33 Further study of autonomic regulation is needed to determine whether changes in sympathovagal balance lead to the overexpression of proinflammatory cytokines in alcoholic subjects.
Alcohol intake is one of the factors known to increase blood pressure levels,34 and the increased morning surge in blood pressure is associated with cardiovascular events in hypertensive patients.3537 However, findings from the present sample of alcohol-dependent men do not necessarily generalize to mild to moderate chronic alcohol intake, which has been associated with slight favorable effects on cardiovascular events in healthy adults.38
Elevated sympathetic responses in alcoholic subjects were found after >3 weeks of abstinence, suggesting that pharmacological action of alcohol is not the cause of these differential responses. In addition, differences in heart rate and catecholamine responsiveness to sleep loss cannot be attributed to factors such as age or black ethnicity, because both of these variables were controlled by matching the 2 groups and by statistical covariance. Whereas it is possible that differences in cigarette smoking histories between the alcoholic subjects and controls could be related to these findings, resting baseline levels of catecholamines before sleep deprivation did not differ between the groups, and smoking status within the alcoholic subjects had no impact on cardiovascular or catecholamine responses. Moreover, the pharmacological effect of nicotine on sympathetic activity was minimized by the assessment of morning levels of epinephrine and norepinephrine after >8 hours since last use of nicotine. Other factors such as physical activity that can alter sympathetic measures were experimentally controlled by restricting all subjects to the supine position across the nocturnal periods. Potential confounders such as education and body mass index were not correlated with measures of epinephrine or norepinephrine at any time point. Finally, in contrast to the differential effects of sleep loss, there was no relationship between sleep architecture measures (eg, delta sleep, rapid eye movement sleep) and measures of cardiovascular and catecholamines on any of the nights.
Given evidence that acute sleep loss and chronic sleep debt alter autonomic, metabolic, and immune functioning,10,20,33,39 the present data indicate that chronic habitual sleep disturbance may have pathophysiological consequences in alcohol dependence. Difficulties with sleep onset and maintenance show a protracted course and persist for months to years after abstinence in recovering alcoholic subjects.40 Second, the physiological effects of sleep loss in alcoholic subjects might be further perpetuated by a failure of sleep recovery.16 Third, sleep loss induces exaggerated increases of IL-6 and TNF, which persist after recovery sleep in alcoholic subjects.31 Increases in the expression of inflammatory markers are implicated in the risk of cardiovascular disease and inflammatory and infectious disorders.30 Fourth, alcohol dependence, as well as sleep deprivation, are thought to increase catecholamine release through activation of central nervous system centers and alterations of sympathovagal balance.11,27,41,42 Alcoholic subjects who have a night of insufficient sleep may be particularly vulnerable to increases of blood pressure and heart rate in the morning.11,12 Cardiovascular events are known to occur more frequently from early morning to noon,14 and longitudinal studies have found that autonomic dysregulation is related to greater risk of cardiovascular disease.43
Perspectives
Sleep deprivation induces elevated heart rate and catecholamine responses in alcoholic subjects as compared with controls, which are sustained after nights of partial and recovery sleep. Increased sympathetic nervous activity that occurs along with habitual sleep loss may play a role in tremor, anxiety, hypertension, and cardiac arrhythmias of abstinent alcoholic subjects.
Studies need to be performed to track recovery of sympathetic activity or lack of recovery over longer periods of time in alcohol dependence. Moreover, it is not known whether these abnormalities of sleep and sympathetic regulation are pre-existing, as might be found in the offspring of alcoholic subjects. Future studies should also explore the potential reversibility of these abnormalities of sleep and physiological functioning in alcohol dependence. Behavioral treatments, which are highly efficacious for the treatment of chronic insomnia,44 may ameliorate abnormalities in sleep and sympathetic reactivity in alcohol dependence.
| Acknowledgments |
|---|
Received October 14, 2004; first decision November 9, 2004; accepted December 3, 2004.
| References |
|---|
|
|
|---|
2. Klatsky AL. Alcohol and cardiovascular diseases: a historical overview. Ann N Y Acad Sci. 2002; 957: 715.[Medline] [Order article via Infotrieve]
3. Djousse L, Levy D, Benjamin EJ, Blease SJ, Russ A, Larson MG, Massaro JM, DAgostino RB, Wolf PA, Ellison RC. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol. 2004; 93: 710713.[CrossRef][Medline] [Order article via Infotrieve]
4. Denison H, Jern S, Jagenburg R, Wendestam C, Wallerstedt S. Influence of increased adrenergic activity and magnesium depletion on cardiac rhythm in alcohol withdrawal. Br Heart J. 1994; 72: 554560.
5. Randin D, Vollenweider P, Tappy L, Jequier E, Nicod P, Scherrer U. Suppression of alcohol-induced hypertension by dexamethasone. N Engl J Med. 1995; 332: 17331737.
6. King AC, Bernardy NC, Parsons OA, Lovallo WR. Hemodynamic alterations in alcohol-related transitory hypertension. Alcohol. 1996; 13: 387393.[CrossRef][Medline] [Order article via Infotrieve]
7. King AC, Errico AL, Parsons OA, Lovallo WR. Blood pressure dysregulation associated with alcohol withdrawal. Alcohol Clin Exp Res. 1991; 15: 478482.[CrossRef][Medline] [Order article via Infotrieve]
8. King AC, Parsons OA, Bernardy NC, Lovallo WR. Drinking history is related to persistent blood pressure dysregulation in postwithdrawal alcoholics. Alcohol Clin Exp Res. 1994; 18: 11721176.[CrossRef][Medline] [Order article via Infotrieve]
9. Irwin M, Thompson J, Miller C, Gillin JC, Ziegler M. Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. J Clin Endocrin Metab. 1999; 84: 19791985.
10. Irwin M, Clark C, Kennedy B, JC G, Ziegler M. Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects. Brain Beh Immun. 2003; 17: 365372.[CrossRef][Medline] [Order article via Infotrieve]
11. Lusardi P, Zoppi A, Preti P, Pesce RM, Piazza E, Fogari R. Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study. Am J Hypertens. 1999; 12: 6368.[Medline] [Order article via Infotrieve]
12. Kato M, Phillips BG, Sigurdsson G, Narkiewicz K, Pesek CA, Somers VK. Effects of sleep deprivation on neural circulatory control. Hypertension. 2000; 35: 11731175.
13. Mallon L, Broman JE, Hetta J. Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. J Intern Med. 2002; 251: 207216.[CrossRef][Medline] [Order article via Infotrieve]
14. Muller JG, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989; 79: 733743.
15. Redwine L, Dang J, Hall M, Irwin M. Disordered sleep, nocturnal cytokines, and immunity in alcoholics. Psychosom Med. 2003; 65: 7585.
16. Irwin M, Gillin JC, Dang J, Weissman J, Phillips E, Ehlers CL. Sleep deprivation as a probe of homeostatic sleep regulation in primary alcoholics. Biol Psychiatry. 2002; 51: 632641.[CrossRef][Medline] [Order article via Infotrieve]
17. Irwin M, Miller C, Gillin JC, Demodena A, Ehlers CL. Polysomnographic and spectral sleep EEG in primary alcoholics: an interaction between alcohol dependence and African-Am ethnicity. Alcohol Clin Exp Res. 2000; 24: 13761384.[CrossRef][Medline] [Order article via Infotrieve]
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 1994.
19. Gillin JC, Smith TL, Irwin M, Kripke DF, Brown S, Schuckit M. Short REM latency in primary alcoholic patients with secondary depression. Am J Psychiatry. 1990; 147: 106109.
20. Redwine L, Hauger RL, Gillin JC, Irwin M. Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J Clin Endocrinol Metab. 2000; 85: 35973603.
21. Ziegler M, Lake CR. The sympathetic nervous system in man: its evaluation and the measurement of plasma NE. In: Lake CR, Chernow B, Feuerstein G, Goldstein DS, Ziegler MD, eds. Norepinephrine. Baltimore: Williams and Wilkins; 1992.
22. Hughes JW, Sherwood A, Blumenthal JA, Suarez EC, Hinderliter AL. Hostility, social support, and adrenergic receptor responsiveness among African-Am and white men and women. Psychosom Med. 2003; 65: 582587.
23. Irwin M, Brown M, Patterson T, Hauger R, Mascovich A, Grant I. Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J. 1991; 5: 31003107.[Abstract]
24. Nicolas JM, Estruch R, Antunez E, Sacanella E, Urbano-Marquez A. Nutritional status in chronically alcoholic men from the middle socioeconomic class and its relation to ethanol intake. Alcohol Alcoholism. 1993; 28: 551558.
25. Keppel G. Design and Analysis: A Researchers Handbook, 2nd ed. Englewood: Prentice-Hall; 1982.
26. Milanov I, Toteva S, Georgiev D. Alcohol withdrawal tremor. Electromyogr Clin Neurophysiol. 1996; 36: 1520.[Medline] [Order article via Infotrieve]
27. Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension. 1996; 27: 13181324.
28. Bernardy NC, King AC, Lovallo WR. Cardiovascular responses to physical and psychological stress in female alcoholics with transitory hypertension after early abstinence. Alcohol Clin Exp Res. 2003; 27: 14891498.[CrossRef][Medline] [Order article via Infotrieve]
29. Panknin TL, Dickensheets SL, Nixon SJ, Lovallo WR. Attenuated heart rate responses to public speaking in individuals with alcohol dependence. Alcohol Clin Exp Res. 2002; 26: 841847.[CrossRef][Medline] [Order article via Infotrieve]
30. Lesperance F, Frasure-Smith N, Theroux P, Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry. 2004; 161: 271277.
31. Irwin M, Rinetti G, Redwine L, Motivala S, Dang J, Ehlers C. Nocturnal proinflammatory cytokine-associated sleep disturbances in abstinent African Am alcoholics. Brain Behav Immun. 2004; 18: 349360.[CrossRef][Medline] [Order article via Infotrieve]
32. Tracey KJ. The inflammatory reflex. Nature. 2002; 420: 853859.[CrossRef][Medline] [Order article via Infotrieve]
33. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999; 354: 14351439.[CrossRef][Medline] [Order article via Infotrieve]
34. Kawano Y, Abe H, Kojima S, Takishita S, Matsuoka H. Effects of repeated alcohol intake on blood pressure and sodium balance in Japanese males with hypertension. Hypertens Res. 2004; 27: 167172.[CrossRef][Medline] [Order article via Infotrieve]
35. Gosse P, Lasserre R, Minifie C, Lemetayer P, Clementy J. Blood pressure surge on rising. J Hypertens. 2004; 22: 11131118.[CrossRef][Medline] [Order article via Infotrieve]
36. Kario K, Pickering TG, Hoshide S, Eguchi K, Ishikawa J, Morinari M, Hoshide Y, Shimada K. Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system. Am J Hypertens. 2004; 17: 668675.[CrossRef][Medline] [Order article via Infotrieve]
37. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003; 107: 14011406.
38. Goldberg IJ. To drink or not to drink? N Engl J Med. 2003; 348: 163164.
39. Irwin M, McClintick J, Costlow C, Fortner M, White J, Gillin JC. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J. 1996; 10: 643653.[Abstract]
40. Drummond SP, Gillin JC, Smith TL, DeModena A. The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res. 1998; 22: 17961802.[CrossRef][Medline] [Order article via Infotrieve]
41. Townshend MM, Smith AJ. Factors influencing the urinary excretion of free catecholamines in man. Clin Sci. 1973; 44: 253265.[Medline] [Order article via Infotrieve]
42. Hawley RJ, Major LF, Schulman EA, Linnoila M. Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Correlations with clinical signs. Arch Gen Psychiatry. 1985; 42: 10561062.
43. Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, Schouten EG. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation. 2000; 102: 12391244.
44. Irwin MR, Cole JC, Nicassio P. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in adults and in older adults 55 + years. Health Psychology. 2004; in press.
This article has been cited by other articles:
![]() |
P. Levy, M. R. Bonsignore, and J. Eckel Sleep, sleep-disordered breathing and metabolic consequences Eur. Respir. J., July 1, 2009; 34(1): 243 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gottschlich, J. Khoury, G. D. Warden, and R. J. Kagan An Evaluation of the Neuroendocrine Response to Sleep in Pediatric Burn Patients JPEN J Parenter Enteral Nutr, May 1, 2009; 33(3): 317 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Irwin, M. Wang, C. O. Campomayor, A. Collado-Hidalgo, and S. Cole Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med, September 18, 2006; 166(16): 1756 - 1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Irwin, E. M. Valladares, S. Motivala, J. F. Thayer, and C. L. Ehlers Association Between Nocturnal Vagal Tone and Sleep Depth, Sleep Quality, and Fatigue in Alcohol Dependence Psychosom Med, January 1, 2006; 68(1): 159 - 166. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |